ArticleCommunications chemistry2025
Structural and allosteric effects of the membrane-bound PI3Kα H1047R mutation and opportunities for drug discovery.
Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A new functional assay reveals that membrane binding is critical for overactivation of the phosphoinositide 3-kinase H1047R mutant.The Journal of biological chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PI3Kα is a lipid kinase that regulates cell growth and survival via the PI3Kα/Akt pathway. As a peripheral membrane protein, PI3Kα is activated at the membrane, however, its active conformation remains unknown. To investigate how PI3Kα and its most prevalent oncogenic mutation, H1047R, interact with the membrane, we performed Molecular Dynamics simulations of active-like PI3Kα WT and H1047R mutant in complex with HRAS on a model membrane. Our simulations reveal that the H1047R mutation enhances substrate coordination, promotes catalytic interactions, and induces an open C-terminal conformation that stabilizes the protein on the membrane. Moreover, H1047R strengthens allosteric coupling between the C-terminus and membrane-binding loop 2 in both solution and membrane-bound states. WT and mutant proteins adopt distinct conformational ensembles on the membrane, enabling structure-based prediction of allosteric pockets at the protein-membrane interface. These findings offer a mechanistic basis for the H1047R enhanced membrane-binding ability and insights for new therapeutic strategies targeting the protein-membrane interface.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.